PIN14 ECONOMIC EVALUATION OF CASPOFUNGIN (CANCIDAS®) VERSUS LIPOSOMAL AMPHOTERICIN B FOR EMPIRICAL THERAPY OF SUSPECTED SYSTEMIC FUNGAL INFECTION IN THE GERMAN HOSPITAL SETTING
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63516-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)63516-4/fulltext
Section Title :
Section Order :
369
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63516-4&doi=10.1016/S1098-3015(10)63516-4